Described are compounds of Formula I and Formula II and their pharmaceutically acceptable salts. The compounds of Formulas I and II are antagonists of NMDA receptor channel complexes useful for treating cerebral vascular disorders such as, for example, cerebral ischemia, cardiac arrest, stroke, and Parkinson's disease.
1
描述了公式I和公式II的化合物及其药学上可接受的盐。公式I和II的化合物是N
MDA受体通道复合物的
拮抗剂,可用于治疗脑血管疾病,例如脑缺血、心脏停搏、中风和帕
金森病。